The Securities Exchange Commission announced on Friday it will make cryptocurrency and initial coin offerings a top priority. Earlier this week crypto traders got an unexpected bit of hope
when the chairman of the SEC testified in front of the Senate Banking Committee and said cryptocurrency shouldn't be dismissed. Peter J. Ferrara, policy analyst and Senior Fellow for Legal Affairs at The Heartland Institute joins The Crypto Craze to discuss what this means for crypto traders.
Ferrara explains a new version of bitcoin called AML bitcoin, which takes the anonymity out of each transaction. He says this change in the technology may flourish if the SEC takes a stronger hold on the regulation of crypto.
Plus, Ferrara believes this is a turning point crypto because now each "wallet" will be tied to a biometric identity. Up until now it's been a little like the wild, wild west. There weren't any laws or sanctions and that caused problems with money laundering and even using crypto as a payment for terrorism.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
